These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 4713273

  • 1. [Remarks on E. Schöpf's report "Side effects of external corticosteroid therapy" (Hautarzt 23, 295 (1972))].
    Hendrikse JC.
    Hautarzt; 1973 Apr; 24(4):165. PubMed ID: 4713273
    [No Abstract] [Full Text] [Related]

  • 2. [Concluding comments of the author on J. C. M. Hendrikse's report on the article: "Side effects of external corticosteroid therapy" (Hautarzt 23, 295 (1972))].
    Schöpf E.
    Hautarzt; 1973 Apr; 24(4):165. PubMed ID: 4713274
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Topical corticosteroid use in children: adverse effects and how to minimize them.
    Saraswat A.
    Indian J Dermatol Venereol Leprol; 2010 Apr; 76(3):225-8. PubMed ID: 20445290
    [No Abstract] [Full Text] [Related]

  • 5. [Side effects of topical corticosteroid therapy. II. Systemic side effects].
    Nitzschner H.
    Z Arztl Fortbild (Jena); 1978 Nov 01; 72(21):1021-4. PubMed ID: 369157
    [No Abstract] [Full Text] [Related]

  • 6. Rebound vasodilation from long-term topical corticosteroid use.
    Rapaport M.
    Arch Dermatol; 2007 Feb 01; 143(2):268-9. PubMed ID: 17310013
    [No Abstract] [Full Text] [Related]

  • 7. Cushing syndrome caused by topical corticosteroid: a case report.
    Gen R, Akbay E, Sezer K.
    Am J Med Sci; 2007 Mar 01; 333(3):173-4. PubMed ID: 17496736
    [Abstract] [Full Text] [Related]

  • 8. [Cushing's syndrome induced by local corticoid therapy].
    Leblac A, Choulot JJ.
    Nouv Presse Med; 1978 May 27; 7(21):1857. PubMed ID: 673740
    [No Abstract] [Full Text] [Related]

  • 9. [Locally acting corticosteroids in inflammatory bowel disease. Are they effective? Are they really less toxic?].
    Nos Mateu P.
    Gastroenterol Hepatol; 2008 Sep 27; 31 Suppl 3():16-21. PubMed ID: 19087859
    [No Abstract] [Full Text] [Related]

  • 10. Cushing's syndrome caused by topical steroid therapy for psoriasis.
    Abma EM, Blanken R, De Heide LJ.
    Neth J Med; 2002 Apr 27; 60(3):148-50. PubMed ID: 12164372
    [Abstract] [Full Text] [Related]

  • 11. Dangers of low-dose corticosteroid therapy in rheumatoid arthritis.
    Ramos-Remus C, Russell AS.
    Bull Rheum Dis; 1997 Jun 27; 46(4):1-4. PubMed ID: 9188202
    [Abstract] [Full Text] [Related]

  • 12. Cushing's syndrome due to topical steroid.
    Cayir A, Kaya A, Davutoğlu S, Küçükaslan I, Ozkan B.
    West Indian Med J; 2013 Jan 27; 62(1):104-5. PubMed ID: 24171340
    [No Abstract] [Full Text] [Related]

  • 13. Picture of the month. Cushing's syndrome due to topical corticosteroids.
    Gemme G, Ruffa G, Bonioli E, Lagorio V, Feingold M.
    Am J Dis Child; 1984 Oct 27; 138(10):987-8. PubMed ID: 6475861
    [No Abstract] [Full Text] [Related]

  • 14. [Topical and systemic corticosteroid therapy for uveitis in childhood].
    Thurau SR, Frosch M, Zierhut M, Gümbel H, Heiligenhaus A.
    Klin Monbl Augenheilkd; 2007 Jun 27; 224(6):516-9. PubMed ID: 17594623
    [Abstract] [Full Text] [Related]

  • 15. Cutaneous reactions to rheumatological drugs.
    Bailin PL, Matkaluk RM.
    Clin Rheum Dis; 1982 Aug 27; 8(2):493-516. PubMed ID: 6216041
    [No Abstract] [Full Text] [Related]

  • 16. [Skin dystrophy after prolonged application of corticosteroid ointments (experimental study)].
    Akimochkina RG, Kalugin VV.
    Vestn Dermatol Venerol; 1969 Aug 27; 43(8):43-6. PubMed ID: 5399011
    [No Abstract] [Full Text] [Related]

  • 17. Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants.
    Cherian MP, AbdulJabbar M.
    Saudi Med J; 2001 Dec 27; 22(12):1139-41. PubMed ID: 11802195
    [No Abstract] [Full Text] [Related]

  • 18. [Therapy with corticosteroids].
    Neuendorf W.
    Z Arztl Fortbild (Jena); 1981 Mar 15; 75(6):247-53. PubMed ID: 6269305
    [No Abstract] [Full Text] [Related]

  • 19. [Lack of compliance to topical corticosteroid therapy: possible cause and solutions].
    Morren MA, Bruwiere I, Lemmens M, Goossens A, Garmyn M.
    J Pharm Belg; 2013 Mar 15; (1):20-7. PubMed ID: 23638609
    [Abstract] [Full Text] [Related]

  • 20. The position not the presence of the halogen in corticosteroids influences potency and side effects.
    Bikowski J, Pillai R, Shroot B.
    J Drugs Dermatol; 2006 Feb 15; 5(2):125-30. PubMed ID: 16485880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.